(Q39403190)

11 September 2017

title

New multiple-agent chemotherapy (B-DOPA) for advanced Hodgkin's disease (English)

2 references

10.1002/1097-0142(197608)38:2<667::AID-CNCR2820380207>3.0.CO;2-1

11 September 2017

https://api.crossref.org/works/10.1002/1097-0142(197608)38:2%3C667::AID-CNCR2820380207%3E3.0.CO;2-1

11 April 2022

1 reference

1 reference

10.1002/1097-0142(197608)38:2<667::AID-CNCR2820380207>3.0.CO;2-1

https://api.crossref.org/works/10.1002/1097-0142(197608)38:2%3C667::AID-CNCR2820380207%3E3.0.CO;2-1

11 April 2022

author name string

Frei E 3rd

2

1 reference

11 September 2017

J. J. Lokich

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A61797

11 April 2022

E. Frei

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A61797

11 April 2022

N. Jaffe

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A61797

11 April 2022

J. Tullis

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A61797

11 April 2022

language of work or name

English

0 references

publication date

1 August 1976

1 reference

full work available at URL

11 September 2017

number of pages

5

1 reference

based on heuristic

inferred from page(s)

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2F1097-0142(197608)38:2%3C667::AID-CNCR2820380207%3E3.0.CO;2-1

1 reference

10.1002/1097-0142(197608)38:2<667::AID-CNCR2820380207>3.0.CO;2-1

https://api.crossref.org/works/10.1002/1097-0142(197608)38:2%3C667::AID-CNCR2820380207%3E3.0.CO;2-1

https://onlinelibrary.wiley.com/doi/full/10.1002/1097-0142(197608)38:2%3C667::AID-CNCR2820380207%3E3.0.CO;2-1

11 April 2022

1 reference

10.1002/1097-0142(197608)38:2<667::AID-CNCR2820380207>3.0.CO;2-1

https://api.crossref.org/works/10.1002/1097-0142(197608)38:2%3C667::AID-CNCR2820380207%3E3.0.CO;2-1

11 April 2022

1 reference

11 September 2017

volume

38

1 reference

11 September 2017

issue

2

1 reference

11 September 2017

page(s)

667-671

1 reference

Adriamycin. A new anticancer drug with significant clinical activity

11 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%28197608%2938%3A2%3C667%3A%3AAID-CNCR2820380207%3E3.0.CO%3B2-1

Combination Chemotherapy in the Treatment of Advanced Hodgkin's Disease

21 January 2018

5

73

881

DeVita

1970

1 reference

10.1002/1097-0142(197608)38:2<667::AID-CNCR2820380207>3.0.CO;2-1

https://api.crossref.org/works/10.1002/1097-0142(197608)38:2%3C667::AID-CNCR2820380207%3E3.0.CO;2-1

Combination chemotherapy in advanced Hodgkin's disease. Induction and maintenance of remission

11 April 2022

7

79

376

Frei

1973

1 reference

10.1002/1097-0142(197608)38:2<667::AID-CNCR2820380207>3.0.CO;2-1

https://api.crossref.org/works/10.1002/1097-0142(197608)38:2%3C667::AID-CNCR2820380207%3E3.0.CO;2-1

Combination chemotherapy of advanced Hodgkin's disease. A review

11 April 2022

9

33

1

Goldsmith

1974

1 reference

10.1002/1097-0142(197608)38:2<667::AID-CNCR2820380207>3.0.CO;2-1

https://api.crossref.org/works/10.1002/1097-0142(197608)38:2%3C667::AID-CNCR2820380207%3E3.0.CO;2-1

Chemotherapy of sarcomas with a combination of adriamycin and dimethyl triazeno imidazole carboxamide

11 April 2022

10

30

1632

Gottlieb

1972

1 reference

10.1002/1097-0142(197608)38:2<667::AID-CNCR2820380207>3.0.CO;2-1

https://api.crossref.org/works/10.1002/1097-0142(197608)38:2%3C667::AID-CNCR2820380207%3E3.0.CO;2-1

MOPP chemotherapy for advanced Hodgkin's disease. Prognostic factors in 81 patients.

11 April 2022

Chemotherapy of Hodgkin's Disease in Studies by Acute Leukemia Group B

12

volume

32

0 references

14

131

396

Nissen

1973

1 reference

10.1002/1097-0142(197608)38:2<667::AID-CNCR2820380207>3.0.CO;2-1

https://api.crossref.org/works/10.1002/1097-0142(197608)38:2%3C667::AID-CNCR2820380207%3E3.0.CO;2-1

Bleomycin, an antitumor antibiotic. Clinical experience in 274 patients

11 April 2022

15

77

861

Yagoda

1972

1 reference

10.1002/1097-0142(197608)38:2<667::AID-CNCR2820380207>3.0.CO;2-1

https://api.crossref.org/works/10.1002/1097-0142(197608)38:2%3C667::AID-CNCR2820380207%3E3.0.CO;2-1

Maintenance chemotherapy for advanced Hodgkin's disease in remission

11 April 2022

16

1339

Young

1973

1 reference

10.1002/1097-0142(197608)38:2<667::AID-CNCR2820380207>3.0.CO;2-1

https://api.crossref.org/works/10.1002/1097-0142(197608)38:2%3C667::AID-CNCR2820380207%3E3.0.CO;2-1

11 April 2022

Identifiers

10.1002/1097-0142(197608)38:2<667::AID-CNCR2820380207>3.0.CO;2-1

1 reference

11 September 2017

1 reference